VEGFA and cancer: In addition, in 2018, Lee et al. developed cancer-specific CPP carriers, called BR2 (RAGLPFQVGRLLRRLLR), to selectively deliver anti-vascular endothelial growth factor siRNAs (siVEGF) to particular cancer cells.